THIOPHENE SULFONAMIDES USEFUL AS CARBONIC ANHYDRASE INHIBITORS
申请人:ALCON LABORATORIES, INC.
公开号:EP0527801B1
公开(公告)日:2002-07-31
US5240923A
申请人:——
公开号:US5240923A
公开(公告)日:1993-08-31
[EN] OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A (BETA)-ADRENERGIC ANTAGONIST
申请人:MERCK & CO., INC.
公开号:WO1992018124A1
公开(公告)日:1992-10-29
(EN) Combinations of a $g(b)-adrenergic antagonist and a topical carbonic anhydrase inhibitor are particularly useful in the treatment of ocular hypertension, especially in patients insufficiently responsive to treatment with $g(b)-adrenergic antagonists.(FR) Combinaisons d'un antagoniste $g(b)-adrénergique et d'un inhibiteur de l'anhydrase carbonique topique particulièrement utiles pour le traitement de l'hypertension oculaire, spécialement chez les patients ne réagissant pas suffisamment au traitement par antagonistes $g(b)-adrénergiques.
Sulfonamides useful as carbonic anhydrase inhibitors
申请人:Alcon Laboratories, Inc.
公开号:US05240923A1
公开(公告)日:1993-08-31
Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.